Is this you?
Request access for South Oklahoma Heart Research with your @okheart.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
South Oklahoma Heart Research
Unclaimed profileIndependent Site · Oklahoma · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall82Recruit61Ops90Sponsor88Ther95
Performance (observed)
Historical trials
592
Completed
341
Terminated/Withdrawn
33
Completion rate
91%
Active now
201
Phase 2
164
Phase 3
308
Realized enrollment
784,142
First study year
1988
Years active
38
Match confidence
high
Enrollment velocity (inf)
20,635
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
1,660
States
Oklahoma
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Children's Oncology Group; SWOG Cancer Research Network; Alliance for Clinical Trials in Oncology; Abbott Medical Devices; Pfizer
CROs
Clinipace Worldwide; PPD Development, LP; Worldwide Clinical Trials
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
rburgan@okheart.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall82
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.